Stock Track | Encompass Health Soars 20.51% in Pre-market on Strong Earnings Beat, Upbeat Guidance and Analyst Upgrade

Stock Track02-06 20:40

Encompass Health Corporation's stock soared 20.51% in pre-market trading on Friday.

The significant surge follows the company's release of better-than-expected fourth-quarter 2025 financial results. Encompass Health reported adjusted earnings per share of $1.46, surpassing analyst estimates of $1.30, while quarterly sales of $1.545 billion also exceeded expectations and grew nearly 10% year-over-year.

Investor sentiment was further bolstered by the company's confident 2026 guidance and a price target increase from Barclays to $153 from $150, reflecting analyst optimism about the company's growth trajectory driven by capacity expansion and favorable demographic trends.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100344349?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-06 20:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100344349","market":"hk","top_or_hot":-1,"title":"Stock Track | Encompass Health Soars 20.51% in Pre-market on Strong Earnings Beat, Upbeat Guidance and Analyst Upgrade","media":"Stock Track","content":"<p>Encompass Health Corporation's stock soared 20.51% in pre-market trading on Friday.</p><p>The significant surge follows the company's release of better-than-expected fourth-quarter 2025 financial results. Encompass Health reported adjusted earnings per share of $1.46, surpassing analyst estimates of $1.30, while quarterly sales of $1.545 billion also exceeded expectations and grew nearly 10% year-over-year.</p><p>Investor sentiment was further bolstered by the company's confident 2026 guidance and a price target increase from Barclays to $153 from $150, reflecting analyst optimism about the company's growth trajectory driven by capacity expansion and favorable demographic trends.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Encompass Health Soars 20.51% in Pre-market on Strong Earnings Beat, Upbeat Guidance and Analyst Upgrade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Encompass Health Soars 20.51% in Pre-market on Strong Earnings Beat, Upbeat Guidance and Analyst Upgrade\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-06 20:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Encompass Health Corporation's stock soared 20.51% in pre-market trading on Friday.</p><p>The significant surge follows the company's release of better-than-expected fourth-quarter 2025 financial results. Encompass Health reported adjusted earnings per share of $1.46, surpassing analyst estimates of $1.30, while quarterly sales of $1.545 billion also exceeded expectations and grew nearly 10% year-over-year.</p><p>Investor sentiment was further bolstered by the company's confident 2026 guidance and a price target increase from Barclays to $153 from $150, reflecting analyst optimism about the company's growth trajectory driven by capacity expansion and favorable demographic trends.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EHC","symbol_name":"Encompass Health Corporation","start_time":0,"source_url":"","article_id":"1100344349","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100344349","pubTimestamp":1770381643,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Encompass Health Corporation's stock soared 20.51% in pre-market trading on Friday.The significant surge follows the company's release of better-than-expected fourth-quarter 2025 financial results....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EHC":"Encompass Health Corporation"},"translate_title":"个股追踪|Encompass Health盘前飙升20.51%，因盈利强劲增长、乐观指引和分析师升级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EHC":1},"content_text":"Encompass Health Corporation's stock soared 20.51% in pre-market trading on Friday.The significant surge follows the company's release of better-than-expected fourth-quarter 2025 financial results. Encompass Health reported adjusted earnings per share of $1.46, surpassing analyst estimates of $1.30, while quarterly sales of $1.545 billion also exceeded expectations and grew nearly 10% year-over-year.Investor sentiment was further bolstered by the company's confident 2026 guidance and a price target increase from Barclays to $153 from $150, reflecting analyst optimism about the company's growth trajectory driven by capacity expansion and favorable demographic trends.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100344349","isCrawlerRequest":true}